Technical

Claude View

The Price Picture

Booking has broken its long-term uptrend. Price sits 5.4% below the 200-day SMA, the 50-day crossed under the 200-day on 20 November 2025 (the anchor event of this report), and the stock is down 9.8% year-to-date. What makes the setup interesting — and the reason this is not simply a "sell the downtrend" call — is the tape over the last month: MACD has flipped positive, RSI is 65, and price has pushed back above the 20-day and 50-day SMAs. The long-term trend is broken; the short-term tape is healing. That tension frames the whole page — and sits cleanly on top of what the Numbers tab flagged: fundamentals are top-decile, but the market stopped paying 35x for them in November.

1. Price snapshot

Almost exactly mid-range in its 52-week band ($150.62 low to $233.58 high — which is also the all-time high). Beta of 1.44 says this moves harder than the market in either direction.

2. Three years of price vs 50 / 200 SMA

This is a downtrend regime that is in the middle of a reflex rally. The last golden cross was January 2023; everything from that date through October 2025 was uptrend, and the November death cross is the first structural break in three years.

3. Relative strength vs SPY and XLY (consumer discretionary)

Over three years BKNG has returned roughly 83% vs SPY's 72% and XLY's 64% — so the absolute compounding edge is intact. But the gap peaked in October 2025 near index 240 and has since collapsed to 183, while SPY kept climbing. The leadership baton has passed to the broad market over the last six months. This is the most underappreciated signal on the page: underperformance is happening against a rising benchmark, which is harder to dismiss as "sector rotation."

4. Momentum — RSI(14) and MACD histogram

RSI is 65 — not overbought, not oversold, but pointed up hard from a sub-40 reading three weeks ago. MACD histogram flipped from negative to positive in mid-March and has widened for four consecutive weekly observations (current histogram 2.26, MACD line 3.20 vs signal 0.95). Near-term momentum (1–3 months) is unambiguously bullish. The question this section does not answer is whether that near-term thrust is enough to reclaim the 200-day — that is the stance question below.

5. Volume & conviction — 12 months

Top volume-spike days (last 10 years)

Two things jump out. First, seven of the ten highest-volume days in a decade were down-days — BKNG trades asymmetrically, with bigger participation on fear than on joy. Second, the recent tape has been thin, not climactic: the last 12 months show no volume event above 3x average. Translation — this bounce is not being pushed by a panic-cover. That reduces the odds it's a durable reversal.

6. Volatility regime

Current 30-day realized vol is 36.0% — sitting almost exactly on the 10-year 80th-percentile line (38.4%). In plain language, the market is pricing in near-top-quintile risk for BKNG specifically. This is consistent with a stock that just lost its 200-day and is in the middle of a fight between bulls and bears. Vol typically resolves by dropping into the p20–p80 corridor within 2–3 months; that resolution will coincide with whichever level breaks first.

7. Technical scorecard + stance

Net score: -2 across six dimensions. The one unambiguous positive is near-term momentum; everything structural is neutral-to-negative.

Stance — neutral-bearish, 3 to 6 months

The long-term trend is broken and the relative-strength leadership has flipped away from BKNG. Momentum has bounced hard enough to short-squeeze back above the 50-day, but not yet hard enough to reclaim the 200-day or re-establish leadership vs SPY. Until the 200-day ($203) is reclaimed on a weekly close, this is a counter-trend rally inside a downtrend. The bearish alternative lives about 10% lower.

• Level above — $203: the rising 200-day SMA. A weekly close above this level invalidates the death cross setup and reopens the $215–$233 range. That is the bullish trigger.
• Level below — $172: the 50-day SMA coinciding with the late-March lows. A daily close under $172 on volume says the March–April bounce was a counter-trend rally and the next stop is the $150 52-week low.

Cross-reference to the Numbers tab. Quant flagged that FY25 net income fell 8% on interest expense and that FY26 operating-margin direction is the single number that matters. Price action agrees: the death cross landed within weeks of the FY25 print showing that margin tailwind. If Q1 2026 delivers margin above 32%, the $203 level breaks. If not, $172 breaks. The two tabs are telling the same story from different sides of the glass.